Oxagen
company
About
Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- £30M
- Industries
- Biopharma,Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£30M
Oxagen has raised a total of
£30M
in funding over 2 rounds. Their latest funding was raised on
Dec 21, 2000 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 21, 2000 | Series Unknown | £30M | 4 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Invesco
|
— | Series Unknown |
|
|
— | Series Unknown |
BankInvest Biomedical Venture
|
— | Series Unknown |
Pacific Rim Ventures
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
